207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study

Authors

Maged Khalil MD, Lehigh Valley Health NetworkFollow
M Rothe
P K. Mangat
E Garrett- Mayer
K F. Mileham
E R. Ahn
H L. Duvivier
L C. Farrington
M Akce
D Behl
P J. Gold
V K. Chiu
N Vijayvergia
C Calfa
A Gaba
F Meric-Bernstam
S M. Schetze
A Gregory
S Halabi
R L. Schilsky

Publication/Presentation Date

10-2023

Volume

34

Issue

2

First Page

265

Last Page

266

Published In/Presented At

https://doi.org/10.1016/j.annonc.2023.09.2930

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division

Document Type

Article